Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-10 7:28 pm Purchase | 2023-02-10 | 13G | IGM Biosciences, Inc. IGMS | Artal Participations S.a r.l | 2,450,000 8.400% | 950,000 (+63.33%) | Filing History |
| 2023-02-10 7:28 pm Purchase | 2022-12-31 | 13G | Aravive, Inc. ARAV | Artal Participations S.a r.l | 12,182,037 9.900% | 10,870,746 (+829.01%) | Filing History |
| 2023-02-10 7:25 pm Sale | 2022-12-31 | 13G | BELLUS Health Inc. BLU | Artal Participations S.a r.l | 3,700,000 2.900% | -4,800,000 (-56.47%) | Filing History |
| 2023-02-10 7:21 pm Unchanged | 2022-12-31 | 13G | Aptinyx Inc. APTX | Artal Participations S.a r.l | 6,116,493 9.000% | 0 (Unchanged) | Filing History |
| 2023-02-10 7:21 pm Unchanged | 2022-12-31 | 13G | Ambrx Biopharma Inc. AMAM | Artal Participations S.a r.l | 15,066,043 5.600% | 0 (Unchanged) | Filing History |
| 2023-02-10 7:15 pm Unchanged | 2022-12-31 | 13G | Achilles Therapeutics plc ACHL | Artal Participations S.a r.l | 2,255,375 5.500% | 0 (Unchanged) | Filing History |
| 2023-02-01 4:30 pm Purchase | 2023-01-23 | 13G | Agenus Inc. AGEN | Artal Participations S.a r.l | 796,411 5.100% | 796,411 (New Position) | Filing History |
| 2022-08-23 4:16 pm Purchase | 2022-08-16 | 13G | Vigil Neuroscience, Inc. VIGL | Artal Participations S.a r.l | 2,285,574 6.400% | 2,285,574 (New Position) | Filing History |
| 2022-08-05 4:31 pm Purchase | 2022-07-28 | 13G | AlloVir, Inc. ALVR | Artal Participations S.a r.l | 242,486 6.000% | 242,486 (New Position) | Filing History |
| 2022-06-24 4:20 pm Purchase | 2022-06-22 | 13G | Scholar Rock Holding Corporation SRRK | Artal Participations S.a r.l | 10,325,042 19.400% | 7,875,042 (+321.43%) | Filing History |
| 2022-02-11 06:47 am Sale | 2021-12-31 | 13G | Seer, Inc. SEER | Artal Participations S.a r.l | 4,750,000 8.300% | -1,090,911 (-18.68%) | Filing History |
| 2022-02-11 06:40 am Purchase | 2021-12-31 | 13G | BELLUS Health Inc. BLU | Artal Participations S.a r.l | 8,500,000 8.200% | 3,750,000 (+78.95%) | Filing History |
| 2022-02-11 06:38 am Purchase | 2022-02-11 | 13G | IGM Biosciences, Inc. IGMS | Artal Participations S.a r.l | 1,500,000 5.800% | 175,000 (+13.21%) | Filing History |
| 2022-02-11 06:35 am Purchase | 2021-12-31 | 13G | Cyclerion Therapeutics, Inc. CYCN | Artal Participations S.a r.l | 138,956 6.400% | 48,077 (+52.90%) | Filing History |
| 2022-02-11 06:33 am Unchanged | 2021-12-31 | 13G | Generation Bio Co. GBIO | Artal Participations S.a r.l | 281,419 4.900% | 0 (Unchanged) | Filing History |
| 2022-02-11 06:31 am Purchase | 2021-12-31 | 13G | Scholar Rock Holding Corporation SRRK | Artal Participations S.a r.l | 2,450,000 7.000% | 350,000 (+16.67%) | Filing History |
| 2022-02-11 06:30 am Purchase | 2021-12-31 | 13G | Leap Therapeutics, Inc. LPTX | Artal Participations S.a r.l | 400,000 4.500% | 100,000 (+33.33%) | Filing History |
| 2022-02-11 06:29 am Sale | 2021-12-31 | 13G | Morphic Holding, Inc. MORF | Artal Participations S.a r.l | 1,585,049 4.300% | -66,637 (-4.03%) | Filing History |
| 2022-02-11 06:28 am Purchase | 2022-02-02 | 13G | Syros Pharmaceuticals, Inc. SYRS | Artal Participations S.a r.l | 350,000 5.600% | 350,000 (New Position) | Filing History |
| 2022-02-11 06:27 am Purchase | 2021-12-31 | 13G | Nanobiotix S.A. NBTX | Artal Participations S.a r.l | 3,069,034 8.800% | 1,036,556 (+51.00%) | Filing History |